patients and clinicians should check the current UK Summary of Product Characteristics (SmPC) for each licensed product (available via the electronic Medicines Compendium, emc) for the most up-to-date adverse reaction information
Saxenda, patients who used Wegovy lost an average of 16% of their weight which proved significantly more than the 8% weight loss that patients who used Saxenda experienced
To view or add a comment, sign in More Relevant Posts The FDA on Thursday handed Novo Nordisk a fast-tracked clearance for a high-dose (HD) version of its blockbuster obesity drug Wegovy (semaglutide)
Kelly MS, Scopelliti EM, Goodson KE, Cma L, Nguyen HX, Simon B
NICE guidance (NG28) recommends GLP-1 receptor agonists like Ozempic for adults with type 2 diabetes when certain criteria are met
While our core weight loss in West Palm Beach program with Semaglutide includes all the essentials, some patients choose optional enhancements for added support